Aetiology and management of extrahepatic portal vein obstruction in children: king's college hospital experience

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 5, 2008, Pages 630-634

  Abd El Hamid, Nehal ^a   Taylor, Rachel M ^a   Marinello, Daniela ^a   Mufti, G J ^a   Patel, Raj ^a   Mieli Vergani, Giorgina ^a   Davenport, Mark ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Endoscopic sclerotherapy; Extrahepatic portal vein obstruction; Gastroesophageal bleeding; Procoagulant profile

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 5 LEIDEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; LIVER ENZYME; LUPUS ANTICOAGULANT; OCTREOTIDE; OMEPRAZOLE; PROPRANOLOL; PROTEIN C; PROTEIN S; SUCRALFATE; VASOPRESSIN;

ADOLESCENT; ADULT; ARTICLE; ASCITES; CHILD; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DUODENOSCOPY; ENDOSCOPY; EROSIVE GASTRITIS; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; ESOPHAGUS VARICES; FEMALE; GASTRIC BANDING; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERSPLENISM; INFANT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; PORTAL VEIN OBSTRUCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLEROTHERAPY; SCREENING; SHUNTING; SPLENOMEGALY; THROMBOCYTE; BLOOD; MEDICAL RECORD; METABOLISM; METHODOLOGY; PATHOLOGY; PORTAL VEIN; THROMBOCYTE COUNT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL RECORDS; PLATELET COUNT; PORTAL VEIN; PROTEIN C; RETROSPECTIVE STUDIES; SCLEROTHERAPY;

EID: 59849108843     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31817b6eea     Document Type: Article

References (35)

1. Gauthier F. Recent concepts regarding extra-hepatic portal hypertension. Semin Pediatr Surg 2005;14:216-25.
2. Bellomo-Brandao MA, Morcillo AM, Hessel G, et al. Growth assessment in children with extra-hepatic portal vein obstruction and portal hypertension. Arq Gastroenterol 2005;40:247.
3. Sharma S, Kumar SI, Poddar U, et al. Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India. Indian J Gastroenterol 2006;25:236-9.
4. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352:1779-90.
5. Patel RK, Lea NC, Henegan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterol 2006;130:2031-8.
6. Conn HO. Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic radiologic and biochemical techniques. J Lab Clin Med 1967;70:442-51.
7. Yadav S, Dutta AK, Sarin SK. Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr 1993;17:392-6.
8. Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extrahepatic portal vein obstruction. Liver Int 2006;26:512-9.
9. Perel Y, Dhermy D, Carrere A, et al. Portal vein thrombosis after splenectomy for hereditary stomatocytosis in childhood. Eur J Pediatr 1999;158:628-30.
10. Gurgey A, Mesci L, Renda Y, et al. Factor V Q 506 mutation in children with thrombosis. Am J Hematol 1996;53:37-9.
11. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8.
12. Gurakan F, Gurgey A, Bakkaloglu A, et al. Homozygous factor V Leiden mutation in a child with Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr 1999;28:516-7.
13. Rangari M, Gupta R, Jain M, et al. Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 2003;23: 434-9.
14. Figen G, Makbule E, Nurten KA, et al. Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up. J Clin Gastroenterol 2004;38:368-72.
15. Seixas CA, Hessel G, Ribeiro CC, et al. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997;77:258-61.
16. Hackeng TM, Sere KM, Tans G, et al. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006;103:3106-11.
17. Seixas CA, Hessel G, Siqueira LH, et al. Study of hemostasis in pediatric patients with portal vein thrombosis. Haematologica 1998;83:955.
18. Korenkov M, Depta A, Kentner R, et al. Paraneoplastic lupus anticoagulans syndrome. Zentralbl Chir 2005;130:372-4.
19. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005;41:603-8.
20. Valla D, Casadevall N, Huisse MG, et al. Aetiology of portal vein thrombosis in adults. A prospective evaluation of primary prolif-erative disorders. Gastroenterology 1988;94:1063-9.
21. Baxter EJ, Scott LM, Campbell PJ. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61.
22. Primigani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44: 1528-34.
23. Kiladjian J, Cervantes F, Leebeek F, et al. Role of JAK2 mutation detection in Budd Chiari syndrome (BCS) and portal vein thrombosis (PVT) associated MPD [abstract]. Blood 2006;108:377.
24. Colaizzo D, Amitrano L, Tiscia GL, et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 2006;5:55-61.
25. Regina S, Herault O, D'Iteroche L, et al. The JAK2 mutation V617F is specifically associated with idiopathic splanchnic vein thrombosis [abstract]. Blood 2006;108:380.
26. McKierman PJ, Beth SV, Davison SM. A prospective study of endoscopic esophageal variceal ligation using multiband ligator. J Pediatr Gastroenterol Nutr 2002;34:207-11.
27. Baroncini D, Milandri GL, Borioni D, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997;27:235-40.
28. Hill ID, Bowie MD. Endoscopic sclerotherapy for control of bleeding varices in children. Am J Gastroenterol 1991;86:472-6.
29. Seidman E, Weber AM, Morin CL, et al. Spinal cord paralysis following sclerotherapy for esophageal varices. Hepatology 1984;4:950-4.
30. Prasad H, Poddar U, Thapa BR, et al. Esophago-pleural fistula following endoscopic sclerotherapy in a child. Gastrointest Endosc 2000;52:804-6.
31. Greenholtz SK, Hall RJ, Sondheimer JM, et al. Manometric and pH consequences of esophageal endosclerosis in children. J Pediatr Surg 1988;23:38-41.
32. Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liv Dis 2002;22:43-58.
33. Mathur SK, Shah SR, Nagral SS, et al. Transabdominal extensive esophagogastric devascularisation gastroesophageal stapling for management of noncirrhotic portal hypertension: long-term results. World J Surg 1999;23:1168-74.
34. Tomoaki K, Rene R, Raghad K, et al. Portosystemic shunting in children during the era of endoscopic therapy: improved postoperative growth parameters. J Pediatr Gastroenterol Nutr 2000;30:419-24.
35. Bambini DA, Superina R, Almond PS, et al. Experience with the Rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension. J Pediatr Surg 2000;35:13-8.